Intrinsic Value of S&P & Nasdaq Contact Us

Biodesix, Inc. BDSX NASDAQ

NASDAQ Global Market • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
47/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$8.67
-28.6%

Stock Statistics — BDSX

Biodesix, Inc. (BDSX) has a market capitalization of $91.67M and trades at $12.14. The 52-week range is 3.44-20.21.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.6, Earnings Per Share (EPS) of $-4.67, annual revenue of $88.5M.

The stock has a beta of 0.57, operates in the Healthcare sector.

Trading Data
Current Price$12.14
52-Week Range3.44-20.21
Volume73.58K
Avg Volume (30D)178.3K
Market Cap$91.67M
Beta (1Y)0.57
Company
IPO Date2020-10-28
Employees273
CEOScott Hutton
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS09075X2071
CUSIP09075X207
Income (Latest Year)
Revenue$88.5M
Gross Profit$66.59M
EBITDA$-21.88M
Operating Income$-27.87M
Net Income$-35.27M
EPS$-4.67
EPS Diluted$-4.67
Shares Outstanding$7.55M
Balance Sheet (Latest Year)
Total Assets$87.48M
Current Assets$32.52M
Cash & ST Investments$18.99M
Total Liabilities$89.94M
Total Debt$72.85M
Net Debt$53.87M
Total Equity$-2.47M
Debt / Equity-29.56
Valuation Ratios
P/E Ratio-2.6
P/S Ratio1.04
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message